A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on… (NCT07246850) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on the Incidence and Duration of Sickness
United States100 participantsStarted 2024-12-30
Plain-language summary
This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of Beekeeper's Naturals Propolis Immune Support Throat Spray on the incidence and duration of sickness over a 16-week period. The study will enroll 100 healthy adults aged 18 to 65.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Be male or female
* Be aged 18-65
* Meet at least one of the following criteria:
Work in a hospital or other healthcare setting Work in a school
* Have a child/children under the age of 10
* Be willing to take the test or placebo product once daily and complete study questionnaires every four weeks for the 16-week study period
* Be willing to refrain from taking any over-the-counter products, herbal remedies, or supplements that target immune function during the study period and for two weeks prior.
* Be willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
* Be in good general health and not live with any uncontrolled chronic conditions.
* Reside in the United States.
Exclusion Criteria:
* Has undergone any surgeries or invasive treatments in the past six months or plans to undergo any during the study period
* Anyone with seasonal allergies
* Anyone who follows a restrictive diet (e.g., keto, vegan, raw, carnivore, etc.).
* Anyone who got a vaccination in the last 2 weeks.
* Anyone taking one or more prescription medications:
Corticosteroids: Prednisone (prednisone), Deltasone (prednisolone), Medrol (methylprednisolone), Decadron (dexamethasone), Cortef (hydrocortisone), Kenalog (triamcinolone), Flonase (fluticasone), Nasonex (mometasone) Biologics (Immunomodulating Agents): Humira (adalimumab), Enbrel (etanercept), Remicade (infliximab), Stelara (ustekinumab), Cosentyx (secukinumab), Taltz (ixe…